Mammaglobin is a recently isolated, novel protein that is homologous to a family of secreted, ligand-binding proteins found in epithelial tissues. Mammaglobin expression is strictly limited to the mammary gland. Furthermore, mammaglobin mRNA and protein are up-regulated in a substantial proportion of breast carcinoma cell lines and tissues. In this proposal three aims are proposed: first, the basic transcriptional regulatory elements will be identified by comparative promoter deletion and gel mobility shift assays in breast and non-breast epithelial cell lines; second, epitope tagging and creating of anti-mammaglobin antisera will be used to examine the quaternary structure, translational regulation, and potential ligand binding capacity; last, the functionality of the promoter elements identified in the first objective will be tested in a transgenic mouse model system.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29CA076223-03
Application #
6137631
Study Section
Metabolic Pathology Study Section (MEP)
Program Officer
Freeman, Colette S
Project Start
1998-01-01
Project End
2002-12-31
Budget Start
2000-01-01
Budget End
2000-12-31
Support Year
3
Fiscal Year
2000
Total Cost
$106,448
Indirect Cost
Name
Washington University
Department
Pathology
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Fleming, T P; Watson, M A (2000) Mammaglobin, a breast-specific gene, and its utility as a marker for breast cancer. Ann N Y Acad Sci 923:78-89
Watson, M A; Dintzis, S; Darrow, C M et al. (1999) Mammaglobin expression in primary, metastatic, and occult breast cancer. Cancer Res 59:3028-31